


| Tiger Asia Intelligence reiterate Buy rating on AnPac Bio, Ltd (NASDAQ:ANPC) |
|
Key Report Highlights: TAI reiterates our Buy rating on ANPC and see tremendous opportunity for AnPac in the Chinese annual physical and cancer screening markets. The solid increase in the number of commercial CDA-based tests and the significant cancer risk assessment database will pave the way for AnPac's long-term growth.
Posted: 2020-06-10 22:48:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.